The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
OTC Anti-Infective Medications-Global Market Insights and Sales Trends 2024
Synopsis
The global OTC Anti-Infective Medications market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of OTC Anti-Infective Medications in various end use industries. The expanding demands from the Hospital Pharmacies, Drug Stores and E-Commerce,, are propelling OTC Anti-Infective Medications market. Antifungals, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antiseptic segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for OTC Anti-Infective Medications, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global OTC Anti-Infective Medications market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global OTC Anti-Infective Medications market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, OTC Anti-Infective Medications sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of OTC Anti-Infective Medications covered in this report include GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche and NanoViricides, etc.
The global OTC Anti-Infective Medications market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
Global OTC Anti-Infective Medications market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global OTC Anti-Infective Medications market, Segment by Type:
Antifungals
Antiseptic
Antiparasitics
Global OTC Anti-Infective Medications market, by Application
Hospital Pharmacies
Drug Stores
E-Commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global OTC Anti-Infective Medications market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of OTC Anti-Infective Medications in various end use industries. The expanding demands from the Hospital Pharmacies, Drug Stores and E-Commerce,, are propelling OTC Anti-Infective Medications market. Antifungals, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antiseptic segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for OTC Anti-Infective Medications, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global OTC Anti-Infective Medications market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global OTC Anti-Infective Medications market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, OTC Anti-Infective Medications sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of OTC Anti-Infective Medications covered in this report include GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche and NanoViricides, etc.
The global OTC Anti-Infective Medications market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
Global OTC Anti-Infective Medications market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global OTC Anti-Infective Medications market, Segment by Type:
Antifungals
Antiseptic
Antiparasitics
Global OTC Anti-Infective Medications market, by Application
Hospital Pharmacies
Drug Stores
E-Commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of OTC Anti-Infective Medications
1.1 OTC Anti-Infective Medications Market Overview
1.1.1 OTC Anti-Infective Medications Product Scope
1.1.2 OTC Anti-Infective Medications Market Status and Outlook
1.2 Global OTC Anti-Infective Medications Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global OTC Anti-Infective Medications Market Size by Region (2018-2029)
1.4 Global OTC Anti-Infective Medications Historic Market Size by Region (2018-2023)
1.5 Global OTC Anti-Infective Medications Market Size Forecast by Region (2024-2029)
1.6 Key Regions, OTC Anti-Infective Medications Market Size (2018-2029)
1.6.1 North America OTC Anti-Infective Medications Market Size (2018-2029)
1.6.2 Europe OTC Anti-Infective Medications Market Size (2018-2029)
1.6.3 Asia-Pacific OTC Anti-Infective Medications Market Size (2018-2029)
1.6.4 Latin America OTC Anti-Infective Medications Market Size (2018-2029)
1.6.5 Middle East & Africa OTC Anti-Infective Medications Market Size (2018-2029)
2 OTC Anti-Infective Medications Market by Type
2.1 Introduction
2.1.1 Antifungals
2.1.2 Antiseptic
2.1.3 Antiparasitics
2.2 Global OTC Anti-Infective Medications Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2018-2023)
2.2.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America OTC Anti-Infective Medications Revenue Breakdown by Type (2018-2029)
2.3.2 Europe OTC Anti-Infective Medications Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific OTC Anti-Infective Medications Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America OTC Anti-Infective Medications Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa OTC Anti-Infective Medications Revenue Breakdown by Type (2018-2029)
3 OTC Anti-Infective Medications Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Drug Stores
3.1.3 E-Commerce
3.2 Global OTC Anti-Infective Medications Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2018-2023)
3.2.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America OTC Anti-Infective Medications Revenue Breakdown by Application (2018-2029)
3.3.2 Europe OTC Anti-Infective Medications Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific OTC Anti-Infective Medications Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America OTC Anti-Infective Medications Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa OTC Anti-Infective Medications Revenue Breakdown by Application (2018-2029)
4 OTC Anti-Infective Medications Competition Analysis by Players
4.1 Global OTC Anti-Infective Medications Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2022)
4.3 Date of Key Players Enter into OTC Anti-Infective Medications Market
4.4 Global Top Players OTC Anti-Infective Medications Headquarters and Area Served
4.5 Key Players OTC Anti-Infective Medications Product Solution and Service
4.6 Competitive Status
4.6.1 OTC Anti-Infective Medications Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline OTC Anti-Infective Medications Products, Services and Solutions
5.1.4 GlaxoSmithKline OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck OTC Anti-Infective Medications Products, Services and Solutions
5.2.4 Merck OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer OTC Anti-Infective Medications Products, Services and Solutions
5.3.4 Pfizer OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis OTC Anti-Infective Medications Products, Services and Solutions
5.4.4 Novartis OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott OTC Anti-Infective Medications Products, Services and Solutions
5.5.4 Abbott OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 Sanofi
5.6.1 Sanofi Profile
5.6.2 Sanofi Main Business
5.6.3 Sanofi OTC Anti-Infective Medications Products, Services and Solutions
5.6.4 Sanofi OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.6.5 Sanofi Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Products, Services and Solutions
5.7.4 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche OTC Anti-Infective Medications Products, Services and Solutions
5.8.4 Roche OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Recent Developments
5.9 NanoViricides
5.9.1 NanoViricides Profile
5.9.2 NanoViricides Main Business
5.9.3 NanoViricides OTC Anti-Infective Medications Products, Services and Solutions
5.9.4 NanoViricides OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.9.5 NanoViricides Recent Developments
5.10 Novabay Pharmaceuticals
5.10.1 Novabay Pharmaceuticals Profile
5.10.2 Novabay Pharmaceuticals Main Business
5.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Products, Services and Solutions
5.10.4 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.10.5 Novabay Pharmaceuticals Recent Developments
5.11 Optimer Pharmaceuticals
5.11.1 Optimer Pharmaceuticals Profile
5.11.2 Optimer Pharmaceuticals Main Business
5.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Products, Services and Solutions
5.11.4 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.11.5 Optimer Pharmaceuticals Recent Developments
5.12 Basilea Pharmaceutica
5.12.1 Basilea Pharmaceutica Profile
5.12.2 Basilea Pharmaceutica Main Business
5.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Products, Services and Solutions
5.12.4 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.12.5 Basilea Pharmaceutica Recent Developments
5.13 MerLion Pharma
5.13.1 MerLion Pharma Profile
5.13.2 MerLion Pharma Main Business
5.13.3 MerLion Pharma OTC Anti-Infective Medications Products, Services and Solutions
5.13.4 MerLion Pharma OTC Anti-Infective Medications Revenue (US$ Million) & (2018-2023)
5.13.5 MerLion Pharma Recent Developments
6 North America
6.1 North America OTC Anti-Infective Medications Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medications Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America OTC Anti-Infective Medications Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 OTC Anti-Infective Medications Market Dynamics
11.1 OTC Anti-Infective Medications Industry Trends
11.2 OTC Anti-Infective Medications Market Drivers
11.3 OTC Anti-Infective Medications Market Challenges
11.4 OTC Anti-Infective Medications Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
